|
|
Volumn 134, Issue 3, 2001, Pages 216-223
|
|
Update in hepatology
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HEPATITIS A ANTIBODY;
HEPATITIS B ANTIBODY;
HEPATITIS VACCINE;
INTERFERON;
LAMIVUDINE;
ANTIBODY TITER;
CLINICAL FEATURE;
DRUG EFFICACY;
HEMOCHROMATOSIS;
HEPATITIS A;
HEPATITIS B;
HEPATITIS C;
HEPATITIS VIRUS;
HUMAN;
INFECTION PREVENTION;
INFECTION RISK;
PRIORITY JOURNAL;
PROGNOSIS;
REVIEW;
RISK ASSESSMENT;
RISK FACTOR;
SYMPTOM;
TREATMENT OUTCOME;
TREATMENT PLANNING;
UNITED STATES;
VACCINATION;
VIRUS HEPATITIS;
VIRUS PATHOGENESIS;
|
|
EID: 0035814839
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-134-3-200102060-00013 Document Type: Review |
|
Times cited : (18)
|
|
References (0)
|
